Funding, M&A and exec moves matched to your market — guaranteed to pay for itself in a year, or we refund it.See plans →
Bio Force Nanosciences Holdings Appoints Richard Kaiser As Interim Chief Executive Officer
PUBLIC · BFNHAug 15, 2026•about 10 hours ago
Position
Chief Financial Officer
Company
BioForce Nanosciences Holdings
ManufacturingBiotechnology
Description
BioForce Nanosciences Holdings announced the appointment of Richard Kaiser as interim Chief Executive Officer while continuing his roles as Chief Financial Officer and Secretary. This decision solidifies leadership continuity amid ongoing corporate developments.
Don't miss BioForce Nanosciences Holdings's next move
Get an email the moment BioForce Nanosciences Holdings changes its leadership, hires an exec, or expands — usually minutes after it happens.
One email per event. Unsubscribe anytime.
Executive Insights
Based on hiring dataNew executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months